SC referrals for lung and non-lung cancer patients in Ontario RCCs. Method: A descriptive analysis was conducted on data submitted to CCO from 14 RCCs on their SC activities among new ambulatory cancer patients in 2017. Data were aggregated and cleaned resulting in 64,635 patient records; two SC performance indicators (Tobacco Screening and Accepted a SC Referral) were calculated by RCC, for lung and non-lung cancer patients. Result: In 2017, 67.8% of all new cancer patients in Ontario were screened for tobacco use (70.2% of lung cancer and 67.5% of non-lung patients). Screening rates for all cancer patients ranged from 51% to 96% across RCCs, with similar ranges for lung and non-lung patients. Within the RCCs, the screening rate differed by up to 12% between lung and non-lung cancer patients. Approximately 17% of all new cancer patients (15% of non-lung patients), seen at RCCs, were identified as current or recent smokers (smoked within the past 6 months), but the proportion was higher among patients with lung cancer at 37%. Overall, 21.5% of all smokers accepted a SC referral (23.7% lung cancer and 20.9% non-lung patients). Rates ranged from 9% to 43% for all cancer patients, with similar ranges observed across patient groups. Within the RCCs, differences of up to 17% were observed in SC referral acceptance rates between lung and non-lung cancer patients. For both the screening and accepted a referral metrics, the direction of the differences was inconsistent, with higher rates observed in lung cancer patients at some RCCs and lower rates at others. Conclusion: In Ontario, more than twice as many lung cancer patients were smokers compared to non-lung cancer patients. Although aggregate provincial Tobacco Screening and Accepted a SC Referral rates showed little difference between these patient groups, large variations in rates for both metrics were observed in RCCs between lung and non-lung patients. Further research is necessary to understand the underlying factors that might be contributing to these wide differences in screening and referral practice.
P2.10-03 Feasibility and Acceptability of E-Cigarettes as an Aid to Quitting Smoking in Lung Cancer Patients: A Pilot Study S. Harrow, 1 L. Bauld, 2 J. Macphee, 1 A. Ford, 2 L. Sinclair, 2 J. Mckell, 2 A. Morrison 3 1 Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow/GB, 2 Institute for Social Marketing Uk Centre for Tobacco and Alcohol Studies, University of Stirling, Stirling/GB, 3 New Nicotine Alliance, Stirling/GB Background: Many patients diagnosed with lung cancer continue to smoke even though this can make treatment less effective and increase side effects. E-cigarettes form part of the UK's tobacco harm reduction policy landscape and are smokers' most popular quit attempt method. This pilot study explores feasibility and acceptability of e-cigarettes to aid smoking cessation among lung cancer patients with advanced disease undergoing chemotherapy. Method: mokers with Stage IV lung cancer were recruited in NHS Greater Glasgow and Clyde and NHS Lanarkshire. Participants were provided with a 2 nd generation e-cigarette device and a four week supply of e-liquid. A baseline home visit was conducted by a researcher and an experienced e-cigarette user. Participants were followed-up over 16 weeks. We explored participants' experiences of using e-cigarettes including CO validated smoking cessation at 4 and 16 weeks. Qualitative interviews were conducted with participants (n¼13), their significant others (n¼6) and health professionals (n¼8) engaged with lung cancer patients to obtain their views on the study. Result: Twentynine patients were recruited and completed baseline data collection. Three patients died during the study. Of the 26 remaining, 35% (n¼9) were CO validated as having stopped smoking at four weeks and 15% (n¼4) at 16 weeks. Study procedures were viewed as feasible and acceptable. Patients' experiences of using e-cigarettes were mixed. Some felt unwell during treatment making stopping smoking more challenging. Those who managed to quit were very positive about ecigarettes as were their significant others. Health professionals expressed concern about longer term e-cigarette safety but welcomed the study. Conclusion: Smoking cessation should be offered to patients who have incurable disease. It is feasible and acceptable to offer e-cigarettes for smoking cessation to lung cancer patients during treatment. Cessation outcomes were positive and comparable with local cessation services. Future research involving a pilot randomised controlled trial is warranted but should include patients with less advanced cancer and assessment of longer term outcomes Keywords: Stage IV, cessation, e-cigarette Background: Prevalence studies have consistently reported higher rates of tobacco use in the South-Eastern parts of Nigeria but little is known about the pattern and factors associated with the intention to quit tobacco use in these parts of the country. The aim of this study was to determine the pattern of tobacco use and intention to quit among residents of Ukpo community of Dunukofia LGA of Anambra State, south eastern Nigeria. Method: A cross-sectional descriptive study was carried out among 490 residents of Ukpo community selected using a two-stage sampling method. Data was collected using pre-tested interviewer administered questionnaires adapted from Global Adult Tobacco Survey. Odd ratios and 95% confidence intervals were computed and P values of < 0.05 were considered statistically significant. Result: The results showed that respondents were mostly male 300(61.2%) and aged between 20 and 70 years with a mean of 42.2 ± 15.4 years. Almost half, 210 (42.9%) had ever used smokeless tobacco. For smoked tobacco, only 116(23.7%) have ever used this form. Age (p<0.0001), male gender (OR 12.78;CI 5.0-31.1; p<0.0001), Persons from the Igbo tribe (p<0.0001) and those with lower educational attainment (p<0.0001) were associated with tobacco use. More people 68 (58.6%) are willing to quit use of smoked tobacco than smokeless tobacco 60(28. 6%). Majority of people who tried to quit smokeless tobacco did so without assistance, 52 (24.1%) Others had used counseling at a cessation clinic 50 (23.1 %), nicotine replacement therapy 26 (12.0%). For smokers, some tried to quit with counseling at a cessation clinic 22 (10.2%) .A few had used nicotine replacement therapy 15 (6.9%), while only 6.5% tried to quit without external assistance. Conclusion: We recommend programmes to help people who are willing to quit tobacco use and establishment of tobacco cessation clinics to help ensure successful tobacco control in Nigeria. Keywords: Intention , quit, tobacco
